{
  "name": "Johnson & Johnson",
  "slug": "johnson-and-johnson",
  "ticker": "JNJ",
  "fetched_at": "2025-12-27T12:22:53.842050+00:00",
  "news": [
    {
      "title": "Johnson & Johnson halts mid-stage trial of experimental eczema drug - CNBC",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOWmtWQ2VXenduR05kY3JtU0F0VXBnRzJHRUo3NEdMU1lXYl9lQ0V4VXFxS2xtdzR5cWFGSWFHSmpfSjBHRmJoQXVYcTZ2UVdoQU9RX1lzNXphaDlqeTA2WHRkUzNmay0xcS1UZnRJUlNBNnNrTU9qeVY2MF83djEteHlWNEJCZGZWQ2NJOVdYTG9aaWNBSnJnN1FUUWpRVWZER0pxaNIBqgFBVV95cUxOUG5SMi1INWVjaG5YTGxCa29qMld5UjJlMHRBdU1Ccmw0WnNxMDBuYUlmb1N5VEJlT1JUQzNWcjY2dGg1aVBDM0JuOVp1YVpEeUJ2V00wQWJNcmk0V0h6S0F2eW5WN0E0TjVHd2UzOGNJLWpiWG9iQWRtcFZERm8tOEVINUJLTm8wOTZzdkgtX2JxRE1QMENRNXZPcVY1VGk3SWxXZHJBeG92dw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxOWmtWQ2VXenduR05kY3JtU0F0VXBnRzJHRUo3NEdMU1lXYl9lQ0V4VXFxS2xtdzR5cWFGSWFHSmpfSjBHRmJoQXVYcTZ2UVdoQU9RX1lzNXphaDlqeTA2WHRkUzNmay0xcS1UZnRJUlNBNnNrTU9qeVY2MF83djEteHlWNEJCZGZWQ2NJOVdYTG9aaWNBSnJnN1FUUWpRVWZER0pxaNIBqgFBVV95cUxOUG5SMi1INWVjaG5YTGxCa29qMld5UjJlMHRBdU1Ccmw0WnNxMDBuYUlmb1N5VEJlT1JUQzNWcjY2dGg1aVBDM0JuOVp1YVpEeUJ2V00wQWJNcmk0V0h6S0F2eW5WN0E0TjVHd2UzOGNJLWpiWG9iQWRtcFZERm8tOEVINUJLTm8wOTZzdkgtX2JxRE1QMENRNXZPcVY1VGk3SWxXZHJBeG92dw?oc=5\" target=\"_blank\">Johnson & Johnson halts mid-stage trial of experimental eczema drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-12-26T13:36:33+00:00",
      "source": "CNBC"
    },
    {
      "title": "Here’s Why Johnson & Johnson (JNJ) Surged in Q3 - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOZUtNRElaZDJGOVJWV3lZSU9UamtxcE9rT2dTYjFMX1JETjZJYk96YVBINjJYN0tOaGM0UUhyb1JfXzI5V3ZvLWd6SmI5TmFGb2ZKU2toRVFZcmV0TU5tZ1pjXzJMaWVXcm82X3dybXFOWTVSOFdRTEtHMjRnMnM2THpn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxOZUtNRElaZDJGOVJWV3lZSU9UamtxcE9rT2dTYjFMX1JETjZJYk96YVBINjJYN0tOaGM0UUhyb1JfXzI5V3ZvLWd6SmI5TmFGb2ZKU2toRVFZcmV0TU5tZ1pjXzJMaWVXcm82X3dybXFOWTVSOFdRTEtHMjRnMnM2THpn?oc=5\" target=\"_blank\">Here’s Why Johnson & Johnson (JNJ) Surged in Q3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-24T13:02:41+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Johnson & Johnson halts mid-stage trial of experimental eczema drug - Reuters",
      "link": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPZ0tqbmFaMW9vU2RwVGxiR0o5MUpVeWFXaVpGWE1vZUp5Wm9ySnVlTkZwUDYwaFFTZXJSNkpDRVN3Z1k3ZGo2QWt6UWdTZE1mVzIwektJZHZlNUoyS0VWelBTNnozanprUFBoZld0TGprVEY4bEtQUUk5azJrVjJzcUtUaUE4eUpvN18zSFpnbW5UWVRwY2Y1SGdrTWRjenAwRkFMRlJaT1Q1SUtzc3lPZ1BiS0JrX1lyalcyQk00N0JGM2c2YVBsWlQzWlFuTE0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizwFBVV95cUxPZ0tqbmFaMW9vU2RwVGxiR0o5MUpVeWFXaVpGWE1vZUp5Wm9ySnVlTkZwUDYwaFFTZXJSNkpDRVN3Z1k3ZGo2QWt6UWdTZE1mVzIwektJZHZlNUoyS0VWelBTNnozanprUFBoZld0TGprVEY4bEtQUUk5azJrVjJzcUtUaUE4eUpvN18zSFpnbW5UWVRwY2Y1SGdrTWRjenAwRkFMRlJaT1Q1SUtzc3lPZ1BiS0JrX1lyalcyQk00N0JGM2c2YVBsWlQzWlFuTE0?oc=5\" target=\"_blank\">Johnson & Johnson halts mid-stage trial of experimental eczema drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-12-26T13:32:40+00:00",
      "source": "Reuters"
    },
    {
      "title": "Johnson & Johnson will appeal talcum powder ruling - CBS News",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOU2FJN1NzdG0wY3c0YUhza2oxa05YOFpBa0gzU1d0STlKWTlSeG5zNUdIeXc5RmdRV3JQemFhUVpDc05PY1pDal9fZkYzeW9QR0xVUjhPSVlSR0JNbVZzRzJOR1V0aURMYUtRdUNDeWRmRWdyZ2lBQm1pNGsxeDBDczNxYURSWWJiZjdxaDdabFE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxOU2FJN1NzdG0wY3c0YUhza2oxa05YOFpBa0gzU1d0STlKWTlSeG5zNUdIeXc5RmdRV3JQemFhUVpDc05PY1pDal9fZkYzeW9QR0xVUjhPSVlSR0JNbVZzRzJOR1V0aURMYUtRdUNDeWRmRWdyZ2lBQm1pNGsxeDBDczNxYURSWWJiZjdxaDdabFE?oc=5\" target=\"_blank\">Johnson & Johnson will appeal talcum powder ruling</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CBS News</font>",
      "published": "2025-12-26T22:28:00+00:00",
      "source": "CBS News"
    },
    {
      "title": "Baltimore jury awards Maryland woman more than $1.5B in Johnson & Johnson lawsuit - Baltimore Sun",
      "link": "https://news.google.com/rss/articles/CBMid0FVX3lxTFAydVNIdVdUWjNBZVFFOGFyLVNaUWhLTF9wOXZ0RTlVVGtYX3RDcG1nSkJUTlVYeGFwN1lTSlhsQngyTm1VRzVyLTZDaWVoWmZJek9QUkVCVGs3Z1lRaXBlQkZpN2hlNmxDaVotTGFZRDhvdmpzRHJN?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMid0FVX3lxTFAydVNIdVdUWjNBZVFFOGFyLVNaUWhLTF9wOXZ0RTlVVGtYX3RDcG1nSkJUTlVYeGFwN1lTSlhsQngyTm1VRzVyLTZDaWVoWmZJek9QUkVCVGs3Z1lRaXBlQkZpN2hlNmxDaVotTGFZRDhvdmpzRHJN?oc=5\" target=\"_blank\">Baltimore jury awards Maryland woman more than $1.5B in Johnson & Johnson lawsuit</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Baltimore Sun</font>",
      "published": "2025-12-24T21:52:30+00:00",
      "source": "Baltimore Sun"
    },
    {
      "title": "Johnson & Johnson (JNJ) Stock: What to Know Before the Market Opens on Dec. 26, 2025 - ts2.tech",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmF4bXdmdjFCdFh1WUZ3S2xjSWNmRGdiamxHXzduRy1OUnlJNEVLZ3FFS0NXOTBBWUd1S0dfV3NiSWtyMEhrblhTenB0S1FEYndJbW4yVHpPVENzS3BvZUJXc2d1cF82NHdXM2lSN0FrajRMaXB2b0JfTksyYTFCZHFBT01mNXQ4bm1NSzlTX0ZEM0N3WTFkaEFwekZPV2M?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmF4bXdmdjFCdFh1WUZ3S2xjSWNmRGdiamxHXzduRy1OUnlJNEVLZ3FFS0NXOTBBWUd1S0dfV3NiSWtyMEhrblhTenB0S1FEYndJbW4yVHpPVENzS3BvZUJXc2d1cF82NHdXM2lSN0FrajRMaXB2b0JfTksyYTFCZHFBT01mNXQ4bm1NSzlTX0ZEM0N3WTFkaEFwekZPV2M?oc=5\" target=\"_blank\">Johnson & Johnson (JNJ) Stock: What to Know Before the Market Opens on Dec. 26, 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">ts2.tech</font>",
      "published": "2025-12-25T23:58:22+00:00",
      "source": "ts2.tech"
    },
    {
      "title": "J&J eczema therapy fails in mid-stage trial (JNJ:NYSE) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOSGZnVmx1WGhyc3Ixd2RWcGV0eXNRdzVHWGRXdTNPMjk4Nkg4R3ByUVo2elAzdmJSLUZKSjNjc25OQTVTUUNWVERjWVpMZVVGZVlXQ0g0c0N3cEpqcjNoeXk2QU1Td1pGaXFoMFdJTjN3NjRpLUN2cXlSSVRXUTRKMURmdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxOSGZnVmx1WGhyc3Ixd2RWcGV0eXNRdzVHWGRXdTNPMjk4Nkg4R3ByUVo2elAzdmJSLUZKSjNjc25OQTVTUUNWVERjWVpMZVVGZVlXQ0g0c0N3cEpqcjNoeXk2QU1Td1pGaXFoMFdJTjN3NjRpLUN2cXlSSVRXUTRKMURmdw?oc=5\" target=\"_blank\">J&amp;J eczema therapy fails in mid-stage trial (JNJ:NYSE)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-12-26T13:30:02+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Johnson & Johnson owes $65.5 million to a woman with cancer who used talcum powder - NBC News",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOeFFPRkJQYkcwTlRSMEFwSmwxclVrcVlRTk1Dd1J6R1BEQk9zQ2poNGFZZHNrNkFRcmQ1OE9CeG5xVGZoQWU4RXJUSlRGcHlJR3BUTUZrOWc5TXRKLVNDeXJ0N0FldlpGNjJBUWwyNVpTQUFJMndWcWJMYW5taWUwTVVjRXp6NFI0UXBDdXFnWnBSOXV0Rm1OZV9oUU9TMktqZEtPb3EwWFlja28wWlFUaXRn0gFWQVVfeXFMTjZ5Z3czV1J4Yk5FTUwxWDJYVldTdG9NLWkwUmxTQ2xpazZWY2F1V3RhbkpzQldNLU81TkIxVEJPUm92d0dWcHh1UzZhOFBkSDRfU3Fqb2c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxOeFFPRkJQYkcwTlRSMEFwSmwxclVrcVlRTk1Dd1J6R1BEQk9zQ2poNGFZZHNrNkFRcmQ1OE9CeG5xVGZoQWU4RXJUSlRGcHlJR3BUTUZrOWc5TXRKLVNDeXJ0N0FldlpGNjJBUWwyNVpTQUFJMndWcWJMYW5taWUwTVVjRXp6NFI0UXBDdXFnWnBSOXV0Rm1OZV9oUU9TMktqZEtPb3EwWFlja28wWlFUaXRn0gFWQVVfeXFMTjZ5Z3czV1J4Yk5FTUwxWDJYVldTdG9NLWkwUmxTQ2xpazZWY2F1V3RhbkpzQldNLU81TkIxVEJPUm92d0dWcHh1UzZhOFBkSDRfU3Fqb2c?oc=5\" target=\"_blank\">Johnson & Johnson owes $65.5 million to a woman with cancer who used talcum powder</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NBC News</font>",
      "published": "2025-12-20T14:54:42+00:00",
      "source": "NBC News"
    }
  ],
  "product_launches": [
    {
      "title": "J&J Gears Up for Some Key New Drug Approvals and Launches - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMickFVX3lxTFBPdUhoMFBEX2lXRzlVb3RUZ1daZkw2Ukt4TEFDSk54S0lrenk5UjNtanp5bXB5YXZiRTBXckFpWkxON0pSYnN5MERDQ3VZY0NNS1A5clE2cndiX3FUdGtkRWx3Zk5faEJoNFBmZ0JGb1FfZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMickFVX3lxTFBPdUhoMFBEX2lXRzlVb3RUZ1daZkw2Ukt4TEFDSk54S0lrenk5UjNtanp5bXB5YXZiRTBXckFpWkxON0pSYnN5MERDQ3VZY0NNS1A5clE2cndiX3FUdGtkRWx3Zk5faEJoNFBmZ0JGb1FfZw?oc=5\" target=\"_blank\">J&amp;J Gears Up for Some Key New Drug Approvals and Launches</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-09-03T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMinAJBVV95cUxNVTk1X25qaHJuQURPZktUYmJQQ3pLTlZqaHJRWjdjcVBfRnRaUVB1UnROekN4aU14ek5DQW5oOW51dmt1M0hTR2tXMG9hMDlzeEVscDNfVWs1cmF4eXlkY1BtVzM0NGtjZVNnSmxwX3Z3X2FHc0haZVJaM1lHWmlwMEpnVkxIalI4LUZ1alNyUlp6emY5b1NCV214WVlBam01QjFNQlFYeTZWOFZLVmpHOFN5LTFsQlVETVZXQWRiVEhZWUdiaFJ6SFNqSTBuMEZKTWptRE5zNUJLNVc4TjFXZWI4WlVOT2hTc1BvZE51S1NmRzR6RHd1YUNkQThwRlJfS0hIcER5dURkYUlOQ1FnTW5fMmVDUUFiSmlYcA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAJBVV95cUxNVTk1X25qaHJuQURPZktUYmJQQ3pLTlZqaHJRWjdjcVBfRnRaUVB1UnROekN4aU14ek5DQW5oOW51dmt1M0hTR2tXMG9hMDlzeEVscDNfVWs1cmF4eXlkY1BtVzM0NGtjZVNnSmxwX3Z3X2FHc0haZVJaM1lHWmlwMEpnVkxIalI4LUZ1alNyUlp6emY5b1NCV214WVlBam01QjFNQlFYeTZWOFZLVmpHOFN5LTFsQlVETVZXQWRiVEhZWUdiaFJ6SFNqSTBuMEZKTWptRE5zNUJLNVc4TjFXZWI4WlVOT2hTc1BvZE51S1NmRzR6RHd1YUNkQThwRlJfS0hIcER5dURkYUlOQ1FnTW5fMmVDUUFiSmlYcA?oc=5\" target=\"_blank\">Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-07-29T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Johnson & Johnson launches daily disposable multifocal toric contact lens - MassDevice",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQUlhsdVdjcDl4bGdLQmdaS0lTNnpWS21CM2F6ZUhNUmRreGU2bUt2UVVfZlE5QllWZ1pxdml6ZjdXWnczeHROQ3J2R3p4YmJGQXhuYkNfZHNXNDQtaXppSEp3cXRyZjRobjREbUh4VDhKUVNzVGhsZXUzaW42em1LRzdnc0VFOVVLZ1lSV1pLdmlucnRCdFVPUF9EekJoMDBK?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxQUlhsdVdjcDl4bGdLQmdaS0lTNnpWS21CM2F6ZUhNUmRreGU2bUt2UVVfZlE5QllWZ1pxdml6ZjdXWnczeHROQ3J2R3p4YmJGQXhuYkNfZHNXNDQtaXppSEp3cXRyZjRobjREbUh4VDhKUVNzVGhsZXUzaW42em1LRzdnc0VFOVVLZ1lSV1pLdmlucnRCdFVPUF9EekJoMDBK?oc=5\" target=\"_blank\">Johnson & Johnson launches daily disposable multifocal toric contact lens</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MassDevice</font>",
      "published": "2025-06-23T07:00:00+00:00",
      "source": "MassDevice"
    },
    {
      "title": "J&J launches Acuvue Oasys Max 1-Day MF contact lens for astigmatism - Eyes On Eyecare",
      "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOWTNPemRKcGRQTVFfUUZUblJ4RDlGYzhtMmpGSjlfUk0xVC1YdFhEQjd3bm44ZGR2UXF0LVFIaDRhNDZ0RTNiLW11MklEb21yc1NFWkdyODBqNklYQ1hxNmJXVGpRd0VnTUpsYnNmcEIzZmV4QjhpVFl3TmtxSFAwMUhZWVp4MTBoOHlvR3RoU2RiTGpOcmJ2WG50djQ2UFVVdF96QU1JbGpRcWZXUURkTTQ4ZE1HcDQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxOWTNPemRKcGRQTVFfUUZUblJ4RDlGYzhtMmpGSjlfUk0xVC1YdFhEQjd3bm44ZGR2UXF0LVFIaDRhNDZ0RTNiLW11MklEb21yc1NFWkdyODBqNklYQ1hxNmJXVGpRd0VnTUpsYnNmcEIzZmV4QjhpVFl3TmtxSFAwMUhZWVp4MTBoOHlvR3RoU2RiTGpOcmJ2WG50djQ2UFVVdF96QU1JbGpRcWZXUURkTTQ4ZE1HcDQ?oc=5\" target=\"_blank\">J&amp;J launches Acuvue Oasys Max 1-Day MF contact lens for astigmatism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Eyes On Eyecare</font>",
      "published": "2025-06-24T07:00:00+00:00",
      "source": "Eyes On Eyecare"
    },
    {
      "title": "Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM - MultiVu",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOVjl3TU8xTVhsSURyUEVkakdIQ1JhdFdydWowaFRZaWlZQXNzZWxzNDlETk1KbXBwd2dJU05Qbnh0QzhsMm9FeE8yUkdKZW1UZUE3UGZ4OFVsRkFrajQwalJKU2RWejJPM2VMME92X3lCa2lYNmd3YV9ZLUNSN2J2dmxiOXM4Znc4S2tJOGZoc3VSUHJCR1hJYUwwSmVJUzRJeWJuR1ltY2RNNWlPVUZyQUdfUTY2SXhET3BURQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxOVjl3TU8xTVhsSURyUEVkakdIQ1JhdFdydWowaFRZaWlZQXNzZWxzNDlETk1KbXBwd2dJU05Qbnh0QzhsMm9FeE8yUkdKZW1UZUE3UGZ4OFVsRkFrajQwalJKU2RWejJPM2VMME92X3lCa2lYNmd3YV9ZLUNSN2J2dmxiOXM4Znc4S2tJOGZoc3VSUHJCR1hJYUwwSmVJUzRJeWJuR1ltY2RNNWlPVUZyQUdfUTY2SXhET3BURQ?oc=5\" target=\"_blank\">Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MultiVu</font>",
      "published": "2025-06-23T07:00:00+00:00",
      "source": "MultiVu"
    }
  ],
  "stock": {
    "ticker": "JNJ",
    "currency": "USD",
    "latest": {
      "date": "2025-12-26",
      "close": 207.6300048828125
    },
    "history": [
      {
        "date": "2025-12-17",
        "close": 210.3300018310547
      },
      {
        "date": "2025-12-18",
        "close": 208.30999755859375
      },
      {
        "date": "2025-12-19",
        "close": 206.3699951171875
      },
      {
        "date": "2025-12-22",
        "close": 207.32000732421875
      },
      {
        "date": "2025-12-23",
        "close": 205.77999877929688
      },
      {
        "date": "2025-12-24",
        "close": 207.77999877929688
      },
      {
        "date": "2025-12-26",
        "close": 207.6300048828125
      }
    ],
    "name": "Johnson & Johnson"
  }
}